Indian Pharma

US Tariff Threat May Hit Indian Pharma Earnings by Up to 10%: SBI Research Warns

US Tariff Threat May Hit Indian Pharma Earnings by Up to 10%: SBI Research Warns

SBI Research warns that a planned 50% tax on Indian pharmaceutical exports could cut profits and hurt India's important role…

4 months ago